FDA Drug recall D-1030-2018
Piperacillin and Tazobactam for Injection USP 3.375 grams per vial, Single-Dose Vial, Rx Only
- FDA Drug
- Class I
- terminated
- Published 2018-07-18
On 2018-07-18 the FDA classified a Class I recall of Piperacillin and Tazobactam for Injection USP 3.375 grams per vial, Single-Dose Vial, Rx Only by Auromedics Pharma, citing presence of Particulate Matter: identified as glass and silicone material.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1030-2018 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2018-07-02 |
| Published | 2018-07-18 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Auromedics Pharma |
| Distribution | US |
Product
Piperacillin and Tazobactam for Injection USP 3.375 grams per vial, Single-Dose Vial, Rx Only. Manufactured for: Auromedics Pharma LLC 6 Wheeling Road Dayton NJ 08810, Made in India. NDC 55150-120-30
Reason
Presence of Particulate Matter: identified as glass and silicone material
Identifiers
| ndc | 55150-119-30 |
|---|---|
| ndc | 55150-120-30 |
| ndc | 55150-121-50 |
| code_info | Lot: PP0317059-A; Exp February 2019: PP0317012-A, Exp: August 2019. |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1030-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.